The following transcript has been edited for clarity.

Hi everybody. I am Jay Chhablani, MD, retina specialist from UPMC Vision Institute. I am here at ARVO 2026 in Denver. This is one of my favorite meetings, where you get to interact with a lot of people, not only ophthalmologists, but also optometrists, vision scientists, and researchers from industry.

As you probably are aware, this year’s ARVO theme is integrating genetics and artificial intelligence (AI), with a focus on precision medicine. This is exactly what I’m seeing here. Some of my favorite sessions were on AI. A few years ago, AI was only being discussed as “what the future holds,” but here I’m seeing that there are already a lot of real-time posters as well as talks where they have applied AI into real-life data and they are showing promising results. In addition to that, there is a lot of focus on geographic atrophy, where we are looking into various biomarkers, particularly ellipsoid zone (EZ) and its validation.

I'm also interested in some of the basic science, where we presented some of our data on assembloid models, where we integrate retinal pigment epithelium (RPE), Bruch’s membrane, and choroidal vessels. And there were a couple of very interesting talks on high-resolution imaging, particularly on the adaptive optics and its use in inflammatory cases as well as in dystrophic cases.

So I think that this ARVO is fulfilling, and I look forward to the next ARVO meeting. Thank you.